ESSILOR (EPA:EL) ESSILOR - Disclosure of Share Capital and Voting Rights Outstanding as of November 30, 2010
Transparency directive : regulatory news
03/12/2010 18:00
Click here to download pdf version
Regulatory Information
Disclosure of Share Capital and Voting Rights Outstanding as of
November 30, 2010
(Pursuant to Article L.233-8 II of the French Commercial Code and articles
221-1 and 223-16 of the General Regulations of the Autorité des Marchés
Financiers)
Charenton-le-Pont, France (December 3, 2010 - 06:00 pm) - As of November 30,
2010, shares and voting rights outstanding of Essilor, the world leader in
ophthalmic optics, broke down as follows:
November 30, 2010
Shares outstanding 213,348,043
Exercisable voting rights 225,916,101
Total potential voting rights, including rights
attached to shares held in treasury and under
the liquidity contract. 231,637,411
The world leader in ophthalmic optical products, Essilor International
researches, develops, manufactures and markets around the world a wide range
of lenses to correct myopia, hyperopia, presbyopia and astigmatism. Its
flagship brands are Varilux(r), Crizal(r), Essilor(r), Definity(r) and
Xperio(TM).
Based in France, the company reported consolidated revenue of EUR3.2 billion
in 2009, with 34,700 employees and operations in 100 countries.
For more information, please visit www.essilor.com.
The Essilor share trades on the NYSE Euronext Paris market and is included in
the CAC 40 index. Codes and symbols: ISIN: FR FR0000121667; Reuters: ESSI.PA;
Bloomberg: EI:FP.
Investor Relations and Financial Communications
www.essilor.com
Phone: +33 (0)1 49 77 42 16